Oramed Pharmaceuticals Inc. Gains 44.37%

Fri, Jul 08, 2022 at 08:31 PM
Oramed Pharmaceuticals Inc. Gains 44.37%

Oramed Pharmaceuticals Inc. (ORMP:NASDAQ) shot up at $8.2, representing a gain of 44.4%. On Fri, Jul 08, 2022, ORMP:NASDAQ hit a New 2-Week High of $8.2. The stock appeared on our News Catalysts scanner on Thu, Jul 07, 2022 at 10:39 AM in the 'LETTER TO STOCKHOLDERS' category. From Fri, Jun 24, 2022, the stock recorded 77.78% Up Days and 70.00% Green Days

About Oramed Pharmaceuticals Inc. (ORMP:NASDAQ)

Oramed Pharmaceuticals Inc is a pharmaceutical company. The Company is engaged in the research and development of pharmaceutical solutions, including an orally ingestible insulin capsule or tablet.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.